ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2014

Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphoma.

Ajay K Gopal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.